https://www.newsweek.com/hydroxychloroquine-questions-intensify-journal-says-its-drug-study-did-not-meet-expected-1496459
In Monday's press briefing, President Trump would not allow his medical expert, Dr. Anthony Fauci, to answer a question about the anti-malarial drug hydroxychloroquine, which has gotten a lot of attention recently as a possible treatment for COVID-19.
In Monday's press briefing, President Trump would not allow his medical expert, Dr. Anthony Fauci, to answer a question about the anti-malarial drug hydroxychloroquine, which has gotten a lot of attention recently as a possible treatment for COVID-19.
This particular question, posed by a CNN reporter, turns out to be especially pertinent: "What is the medical evidence?"
Three
days before, on April 3, the publisher of the scientific paper that
first brought the drug to the attention of public health experts--and
President Trump—cast doubt on the reliability of the original research.
"The
article does not meet the [publisher's] expected standard," said the
International Journal of Anti-Microbial Agents in a statement. The
journal, which published "Hydroxychloroquine and azithromycin as a treatment of Covid-19: results of an open-label non-randomized clinical trial" on March 20 after an accelerated peer review, stopped short of retracting the article.